公开(公告)号：KR20180052631A

公开(公告)日：2018-05-18

申请号：KR20187007130

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENE ,  BROGGINI DIEGO FERNANDO DOMENICO ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: C07D401/14 ,  A61K31/5513 ,  A61P35/00 ,  C07D403/14

CPC classification number: C07D401/14 ,  A61K31/5513 ,  C07D403/14

Abstract: 본발명은신규퀴놀린, 피리도피라진, 나프티리딘및 퀴나졸리논유도체화합물, 상기화합물을포함하는약제학적조성물, 상기화합물의제조를위한방법및 질환, 예를들어암의치료에있어서상기화합물의용도에관한것이다.

公开(公告)号：KR20180052623A

公开(公告)日：2018-05-18

申请号：KR20187006801

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENE ,  BROGGINI DIEGO FERNANDO DOMENICO ,  COLOMBEL HELENE FRANCE SOLANGE ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: C07D487/04 ,  A61K31/5513 ,  A61P35/00 ,  C07D471/04

CPC classification number: C07D487/04 ,  C07D471/04

Abstract: 본발명은신규퀴녹살린, 퀴놀린및 퀴나졸리논유도체화합물, 상기화합물을포함하는약제학적조성물, 상기화합물의제조를위한방법및 질환, 예를들어암의치료에있어서상기화합물의용도에관한것이다.

公开(公告)号：DK3353177T3

公开(公告)日：2020-08-24

申请号：DK16770011

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENÉ ,  BROGGINI DIEGO FERNANDO DOMENICO ,  COLOMBEL HÉLÈNE FRANCE SOLANGE ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: C07D471/04 ,  A61K31/519 ,  A61P35/00 ,  C07D487/04

公开(公告)号：AU2016328693A1

公开(公告)日：2018-03-08

申请号：AU2016328693

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENÉ ,  BROGGINI DIEGO FERNANDO DOMENICO ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: C07D401/14 ,  A61K31/5513 ,  A61P35/00 ,  C07D403/14

Abstract: The invention relates to new quinoline, pyridopyrazine, naphthyridine and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

公开(公告)号：DK3353164T3

公开(公告)日：2022-01-24

申请号：DK16770484

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENÉ ,  BROGGINI DIEGO FERNANDO DOMENICO ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: A61P35/02

公开(公告)号：AU2016328693B2

公开(公告)日：2021-03-11

申请号：AU2016328693

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENÉ ,  BROGGINI DIEGO FERNANDO DOMENICO ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: C07D401/14 ,  A61K31/5513 ,  A61P35/00 ,  C07D403/14

Abstract: The invention relates to new quinoline, pyridopyrazine, naphthyridine and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

公开(公告)号：HRP20220012T1

公开(公告)日：2022-04-01

申请号：HRP20220012

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENÉ ,  BROGGINI DIEGO FERNANDO DOMENICO ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: A61P35/02

公开(公告)号：SI3353177T1

公开(公告)日：2020-08-31

申请号：SI201630856

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENE ,  BROGGINI DIEGO FERNANDO DOMENICO ,  COLOMBEL HELENE FRANCE SOLANGE ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: C07D471/00 ,  A61K31/00 ,  A61P35/00 ,  C07D487/00

公开(公告)号：AU2016328692A1

公开(公告)日：2018-03-01

申请号：AU2016328692

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENE ,  BROGGINI DIEGO FERNANDO DOMENICO ,  COLOMBEL HELENE FRANCE SOLANGE ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: C07D471/04 ,  A61K31/519 ,  A61P35/00 ,  C07D487/04

Abstract: The invention relates to new quinoxaline, quinoline and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

公开(公告)号：RU2747645C2

公开(公告)日：2021-05-11

申请号：RU2018113718

申请日：2016-09-22

Applicant: JANSSEN PHARMACEUTICA NV

Inventor： ANGIBAUD PATRICK RENE ,  BROGGINI DIEGO FERNANDO DOMENICO ,  COLOMBEL HELENE FRANCE SOLANGE ,  CUYCKENS FILIP ALBERT C ,  HOSTYN STEVEN ANNA ,  JONES RUSSELL MARK ,  QUEROLLE OLIVIER ALEXIS GEORGES ,  VERMEULEN WIM

IPC: C07D471/04 ,  A61K31/519 ,  A61P35/00 ,  C07D487/04

Abstract: Изобретениеотноситсяк новымсоединениямформулы (I), кфармацевтическимкомпозициям, содержащимуказанныесоединения, ик применениюуказанныхсоединенийв лечениизаболеваний, опосредованныхактивностью FGFR, напримеррака. 6 н. и 14 з.п. ф-лы, 3 табл., 6 пр.(I).